Kirkland Signature Smoked Salmon products recalled in October 2024 are now considered to be a Class 1 recall, the FDA’s most ...

Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million ...

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will take Accolade private.

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

GI Innovation announced on the 20th that it has signed a memorandum of understanding (MOU) with the Chinese bio company ...

Trump agriculture secretary nominee Brooke Rollins says bird flu will be 'one of the very top priorities' for USDA if she is ...

An investigational, novel combination therapy, consisting of an N-methyl-D-aspartate receptor-modulating drug (ketamine) delivered intravenously (IV) in combination with manualized relapse prevention ...

ExThera Medical has been awarded funding by the Medical Technology Enterprise Consortium (MTEC) to perform a randomized controlled trial to evaluate the efficacy of the Seraph ® 100 Microbind ® ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications ...